Uncategorized

Merck partner reveals bispecific data; Biogen pays $100M for antibody rights

Merck partner reveals bispecific data; Biogen pays $100M for antibody rights

Published

on

Merck partner reveals first human data for PD-1xVEGF bispecific: Sino Biopharm revealed that six of 11 lung cancer patients responded to a low dose of the drug, known as MK-2010, while four of nine patients …​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version